Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes.
about
Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infectionStructural and biochemical characterization of Plasmodium falciparum 12 (Pf12) reveals a unique interdomain organization and the potential for an antiparallel arrangement with Pf41Structure of the Plasmodium 6-cysteine s48/45 domainType II fatty acid biosynthesis is essential for Plasmodium falciparum sporozoite development in the midgut of Anopheles mosquitoesDisruption of the Plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasitesProtective immunity to liver-stage malariaRemoval of heterologous sequences from Plasmodium falciparum mutants using FLPe-recombinasePreerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by designA Novel and Conserved Plasmodium Sporozoite Membrane Protein SPELD is Required for Maturation of Exo-erythrocytic FormsAMA1 and MAEBL are important for Plasmodium falciparum sporozoite infection of the liverMalaria vaccines: where next?Three members of the 6-cys protein family of Plasmodium play a role in gamete fertilityThe Ig domain protein CD9P-1 down-regulates CD81 ability to support Plasmodium yoelii infectionMalaria parasite development in the mosquito and infection of the mammalian host.Engineering of Genetically Arrested Parasites (GAPs) For a Precision Malaria VaccinePlasmodium P36 determines host cell receptor usage during sporozoite invasionSporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum.Plasmodium protease ROM1 is important for proper formation of the parasitophorous vacuole.Advances and challenges in malaria vaccine development.Malaria Parasite Liver Infection and Exoerythrocytic Biology.Host cell phosphatidylcholine is a key mediator of malaria parasite survival during liver stage infection.A genetically attenuated malaria vaccine candidate based on P. falciparum b9/slarp gene-deficient sporozoitesPlasmodium Cysteine Repeat Modular Proteins 3 and 4 are essential for malaria parasite transmission from the mosquito to the host.Liver-Stage Specific Response among Endemic Populations: Diet and Immunity.A next-generation genetically attenuated Plasmodium falciparum parasite created by triple gene deletion.Analysis of a Multi-component Multi-stage Malaria Vaccine Candidate--Tackling the Cocktail ChallengeThe Structure of Plasmodium falciparum Blood-Stage 6-Cys Protein Pf41 Reveals an Unexpected Intra-Domain Insertion Required for Pf12 Coordination.Immunological Cross-Reactivity between Malaria Vaccine Target Antigen P48/45 in Plasmodium vivax and P. falciparum and Cross-Boosting of Immune Responses.Genetically engineered, attenuated whole-cell vaccine approaches for malaria.IFNγ Responses to Pre-erythrocytic and Blood-stage Malaria Antigens Exhibit Differential Associations With Past Exposure and Subsequent Protection.Multidrug ATP-binding cassette transporters are essential for hepatic development of Plasmodium sporozoites.Approaches to malaria vaccine development using the retrospectroscope.Malaria parasite pre-erythrocytic infection: preparation meets opportunity.Antigens for pre-erythrocytic malaria vaccines: building on success.Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes: molecular insight into sex-specific processes and translational repression.Cell biology and immunology of malaria.Plasmodium falciparum malaria vaccines: current status, pitfalls and future directions.Cell and tissue engineering for liver disease.Live attenuated pre-erythrocytic malaria vaccines.Infectivity of Plasmodium falciparum sporozoites determines emerging parasitemia in infected volunteers.
P2860
Q56559646-33831E13-45E6-436F-BF06-CF6C39D3D993Q56710646-2F990A18-96B2-4B5B-A659-A10DA146A27FQ59729220-CA012E37-312E-46AD-87FB-2C672C0E69AFQ59871853-D1FEC880-975F-4204-96D5-8B1735DF6BCCQ59951103-1DD66B8D-3519-49C8-9103-97A848B5C0D5Q59952388-0BEA6039-75C6-45DC-AC37-39FDEF27128BQ59970265-4812EFFE-BDD2-47B1-ABFE-27E0773A592DQ59972533-B6977403-E9F4-46C7-B78A-4306B34D9AE4
P1343
Q24628167-D9BBBB3E-49EF-4133-A3F5-DFC43A6FEE72Q27230051-2D336BDB-2D40-47AC-A1DD-10100BBC42A4Q27678432-0EBE6094-8940-4C70-8D1E-B50890566CC1Q27973456-B680832F-7FB7-46C6-88D0-32AE454EBFC3Q27974558-6C57C945-DF0B-44E2-91A4-29EBB6288B90Q28068626-CA0DDCDD-A617-409F-A4A8-9E786E5EC548Q28476396-AE8FA3FA-9AA9-4B50-8581-2E95BB0A0AD6Q30043830-F88D6D57-B1EB-47BD-B893-371A091423C4Q30044206-CCEAAF19-7CEC-4BFB-A224-72021F281D34Q30044955-96219554-E0FE-46A1-A944-F30FA9BE307DQ33513966-BBA3B301-3EB6-42F8-A95E-E9A38A4F0EA5Q33553363-C0D8CCAE-8840-4B24-A39F-D7632234C741Q33553648-9348AF74-4469-4AE1-8FFD-7878AB35BE3CQ33738231-45DC970D-C782-4A6E-8E41-8319E577DEF5Q33744460-9768C0EC-B3BE-4597-9A1F-940C9B310A53Q33798033-DDEAABE6-1F37-4B6B-8FB8-8886BE9C766DQ33960093-D948896A-CBE3-48A2-9C72-3D691CC5C3C6Q34016204-897933E5-A547-4B3F-BA4F-BA7DB21CDE61Q34145333-91B76A0C-95D7-48AF-A7B8-E1961F170FC6Q34552223-953B39AC-9137-4E96-85FE-2052B7891F77Q34742789-C411DF9B-6A6E-488D-9B16-A4AD50E9E47EQ34753532-C8AC758E-2A5C-4779-B5D2-E59634AC1F54Q34871838-33B1E072-D3D3-4776-BE80-E7BBF74C1BA6Q35199926-9EDC7860-4E03-41E5-ADB8-112117A9AAB5Q35618598-DAA33EFE-B04B-41E7-8288-C189E3A7DF70Q35683366-2C5591D1-4656-4B10-ACCE-536C9EE9B256Q35790481-C7B17092-86CA-4AE0-92BD-375B0070FF7AQ36082968-D6DCBC4D-7C1F-4E55-837A-A16A3A597582Q36811011-28EB4CA8-055A-4E8D-BFB2-D1488E90C804Q36812832-0E1B0257-22AC-4EC4-8DB9-65206A35F742Q37173948-D69D66D2-EC53-4EFC-B187-629840C0287CQ37274832-6D25DE41-B3E8-4D08-ACA0-CBF9408EF366Q37533146-9203DF6C-5D14-47AE-A1A8-0C1052F4FCE6Q37582431-E3A2A666-38F0-4A45-B035-A8E21F11FDE7Q37623775-B391DFB7-A2B8-4304-86DD-623889755923Q37846879-31085340-CCFD-4A86-8C46-2FFAF6216DE3Q38059751-0693A282-E9F4-40A6-93F4-3CEBEE84ECA4Q38230357-5110DD1F-6FF5-4815-8E86-DCE585ED626CQ38284696-4FA76BE3-A040-455E-AEF8-5E7A2FE22C51Q38714971-0D5CD9D4-CB60-406C-81A4-7037A23D6B48
P2860
Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Gene disruption of Plasmodium ...... red primary human hepatocytes.
@ast
Gene disruption of Plasmodium ...... red primary human hepatocytes.
@en
type
label
Gene disruption of Plasmodium ...... red primary human hepatocytes.
@ast
Gene disruption of Plasmodium ...... red primary human hepatocytes.
@en
prefLabel
Gene disruption of Plasmodium ...... red primary human hepatocytes.
@ast
Gene disruption of Plasmodium ...... red primary human hepatocytes.
@en
P2093
P2860
P50
P921
P1433
P1476
Gene disruption of Plasmodium ...... red primary human hepatocytes.
@en
P2093
Andrew P Waters
Audrey Gego
Ben C L van Schaijk
Dominique Mazier
Jean-Francois Franetich
Melissa R van Dijk
Samir Yalaoui
P2860
P356
10.1371/JOURNAL.PONE.0003549
P407
P50
P577
2008-10-28T00:00:00Z